Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Algeta to Participate in Upcoming Investor Conferences


Print article Print article
© Marketwire 2013
2013-02-20 07:11:45 -

OSLO, NORWAY -- (Marketwire) -- 02/20/13 -- Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces that
members of
its senior management team will participate in the following upcoming
investor
conferences:



Citi Global Healthcare Conference 2013



Date: 25-27 February 2013



Participants:



Jeff Albers (President, Algeta US)





Mike Booth (IR)



Panel date & time: Tuesday 25 February, 2013, 10:20am EST



Venue: New York, NY, USA




Credit Suisse Global Healthcare One-on-One Conference



Date: 5-6 March 2013



Participants:



Andrew Kay (President & CEO)



Oystein Soug (CFO)



Mike Booth (IR)



Venue: London, UK




Carnegie Nordic Healthcare Seminar



Date: 12 March 2013



Participants:



Thomas Ramdahl (EVP & CTO)



Renate Birkeli (IR)



Presentation date & time: Tuesday 12 March, 2013, 10:05am CET



Venue: Stockholm, Sweden





Presentations, where applicable, will be available to download at
www.algeta.com : www.algeta.com
following these events.



###



About Algeta



Algeta is a company focused on developing novel targeted therapies for
patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,
based in
Cambridge, MA performing commercial marketing operations in the US. Algeta
is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information
please
visit www.algeta.com : www.algeta.com .



Press release:



hugin.info/134655/R/1679224/548304.pdf : hugin.info/134655/R/1679224/548304.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:



(i) the releases contained herein are protected by copyright and
other applicable laws; and



(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.



Source: Algeta ASA via Thomson Reuters ONE



[HUG#1679224]




For further information, please contact:

Mike Booth / Renate Birkeli
+47 23 00 67 32
Communications & Corporate Affairs
Email Contact : www2.marketwire.com/mw/emailprcntct?id=F2BD86365A4F211C

Media enquiries:
Mark Swallow
+44 207 638 9571

Citigate Dewe Rogerson
Email Contact : www2.marketwire.com/mw/emailprcntct?id=E113B6B588E70BF3

Knut Ekern
+47 22 04 82 00

Gambit Hill & Knowlton
Email Contact : www2.marketwire.com/mw/emailprcntct?id=70B0DBF8D731B7DD

Kari Watson
+1 781 235 3060

MacDougall Biomedical Communications
Email Contact : www2.marketwire.com/mw/emailprcntct?id=9070CB9E36276544

US investor enquiries:
Tricia Swanson
+1 646 378 2953

The Trout Group
Email Contact : www2.marketwire.com/mw/emailprcntct?id=7623DD165070A2E6



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com